115 related articles for article (PubMed ID: 18299137)
1. Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells.
Brito JL; Davies FE; Gonzalez D; Morgan GJ
J Immunol Methods; 2008 Apr; 333(1-2):147-55. PubMed ID: 18299137
[TBL] [Abstract][Full Text] [Related]
2. Transfection of siRNAs in multiple myeloma cell lines.
Brito JL; Brown N; Morgan GJ
Methods Mol Biol; 2010; 623():299-309. PubMed ID: 20217559
[TBL] [Abstract][Full Text] [Related]
3. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
[TBL] [Abstract][Full Text] [Related]
4. Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNA.
Ji J; Wernli M; Mielgo A; Buechner SA; Erb P
Gene Ther; 2005 Apr; 12(8):678-84. PubMed ID: 15660112
[TBL] [Abstract][Full Text] [Related]
5. A simple and cost-effective method to transfect small interfering RNAs into pancreatic cancer cell lines using polyethylenimine.
Wirth M; Fritsche P; Stojanovic N; Brandl M; Jaeckel S; Schmid RM; Saur D; Schneider G
Pancreas; 2011 Jan; 40(1):144-50. PubMed ID: 20938367
[TBL] [Abstract][Full Text] [Related]
6. A novel approach for evaluating the efficiency of siRNAs on protein levels in cultured cells.
Wu W; Hodges E; Redelius J; Höög C
Nucleic Acids Res; 2004 Jan; 32(2):e17. PubMed ID: 14739231
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokine induction by siRNAs is cell type- and transfection reagent-specific.
Yoo JW; Hong SW; Kim S; Lee DK
Biochem Biophys Res Commun; 2006 Sep; 347(4):1053-8. PubMed ID: 16857170
[TBL] [Abstract][Full Text] [Related]
8. Kinetic and efficacy analysis of RNA interference in stably and transiently expressing cell lines.
Grayson AC; Ma J; Putnam D
Mol Pharm; 2006; 3(5):601-13. PubMed ID: 17009859
[TBL] [Abstract][Full Text] [Related]
9. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.
Morgan-Lappe SE; Tucker LA; Huang X; Zhang Q; Sarthy AV; Zakula D; Vernetti L; Schurdak M; Wang J; Fesik SW
Cancer Res; 2007 May; 67(9):4390-8. PubMed ID: 17483353
[TBL] [Abstract][Full Text] [Related]
10. Nucleofection is a highly effective gene transfer technique for human melanoma cell lines.
Han SY; Gai W; Yancovitz M; Osman I; Di Como CJ; Polsky D
Exp Dermatol; 2008 May; 17(5):405-11. PubMed ID: 18312380
[TBL] [Abstract][Full Text] [Related]
11. Efficient selection of silenced primary cells by flow cytometry.
Martínez-Ferrandis JI; Soriano MA; Martínez-Romero A; Herrera G; Cervantes A; O'Connor JE; Knecht E; Armengod ME
Cytometry A; 2007 Aug; 71(8):599-604. PubMed ID: 17458885
[TBL] [Abstract][Full Text] [Related]
12. Variability in RNA interference in neuroendocrine PC12 cell lines stably transfected with an shRNA plasmid.
Cahill AL; Moore JM; Sabar FI; Harkins AB
J Neurosci Methods; 2007 Nov; 166(2):236-40. PubMed ID: 17767962
[TBL] [Abstract][Full Text] [Related]
13. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
14. [Construction and identification of a multiple myeloma-specific APE1 siRNA expression vector].
Yang ZZ; Chen XH; Wang D; Wang G; Xiang DB
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):235-9. PubMed ID: 16875553
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
Koldehoff M; Beelen DW; Elmaagacli AH
J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of BAK gene silencing in aluminum induced neural cell degeneration.
Zhang QL; Niu Q; Shi YT; Niu PY; Liu CY; Zhang L; Zhang C
J Inorg Biochem; 2009 Nov; 103(11):1514-20. PubMed ID: 19740541
[TBL] [Abstract][Full Text] [Related]
17. Designing and utilization of siRNAs targeting RNA binding proteins.
Kim DH; Behlke M; Rossi JJ
Methods Mol Biol; 2008; 488():367-81. PubMed ID: 18982303
[TBL] [Abstract][Full Text] [Related]
18. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.
Weber N; Ortega P; Clemente MI; Shcharbin D; Bryszewska M; de la Mata FJ; Gómez R; Muñoz-Fernández MA
J Control Release; 2008 Nov; 132(1):55-64. PubMed ID: 18727943
[TBL] [Abstract][Full Text] [Related]
19. Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis.
Inoue Y; Kurihara R; Tsuchida A; Hasegawa M; Nagashima T; Mori T; Niidome T; Katayama Y; Okitsu O
J Control Release; 2008 Feb; 126(1):59-66. PubMed ID: 18055057
[TBL] [Abstract][Full Text] [Related]
20. [Construction of shRNA eucharyotic expression plasmid targeted human VIGILIN and the investigation of VIGILIN's effect on hepatocarcinoma cell cycle].
Xie XY; Wei L; Yang WL; Ge YJ; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):527-30, 539. PubMed ID: 18798485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
